PCSA
Processa Pharmaceuticals, Inc.Company with tickers: PCSA
CIK
1533743
CUSIP
74275C403
Shares Outstanding
2,750,173
13F Activity (30d)
8 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 10-K | 2026-03-18 | 2025-12-31 | |
| 8-K | 2026-02-19 | 2026-02-12 | |
| 8-K | 2026-01-07 | 2026-01-06 | |
| 8-K | 2025-12-15 | 2025-12-12 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K/A | 2025-09-16 | 2025-09-11 | |
| 8-K | 2025-09-12 | 2025-09-11 | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-25 | — | |
| 8-K/A | 2025-08-14 | 2025-08-04 | |
| 8-K | 2025-08-08 | 2025-08-07 | |
| 8-K | 2025-08-07 | 2025-08-04 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-25 | — | |
| 8-K | 2025-07-18 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-07-01 | 2025-06-27 | |
| 8-K | 2025-06-30 | 2025-06-24 | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-17 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2025-02-10 | 2025-02-04 | |
| 8-K | 2025-01-30 | 2025-01-27 | |
| 8-K | 2024-11-06 | 2024-10-31 | |
| 10-Q | 2024-10-30 | 2024-09-30 | |
| 8-K | 2024-10-02 | — | |
| 8-K | 2024-08-28 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-17 | 2024-07-16 | |
| 8-K | 2024-07-02 | 2024-06-28 | |
| 8-K | 2024-05-21 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-04-11 | — | |
| 8-K | 2024-04-04 | 2024-04-03 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-02-21 | 2024-02-20 | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2024-01-30 | 2024-01-26 | |
| 8-K | 2024-01-25 | — | |
| 8-K | 2024-01-19 | — | |
| 8-K | 2024-01-18 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-19 | — |
Showing 1–50 of 130 filings